D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QD
1526
Qudian
QD
$707M
| $1.99M | ﹤0.01% |
392,407
+366,617
| +1,422% | +$1.86M |
|
1527
Marvell Technology
MRVL
$58.1B
| $1.98M | ﹤0.01% |
99,709
+57,328
| +135% | +$1.14M |
|
|
ARRY
1528
DELISTED
Array Biopharma Inc
ARRY
| $1.98M | ﹤0.01% |
81,394
+64,794
| +390% | +$1.58M |
|
1529
OrthoPediatrics
KIDS
$493M
| $1.98M | ﹤0.01% |
44,833
+32,799
| +273% | +$1.45M |
|
|
RTL
1530
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $1.98M | ﹤0.01% |
+183,225
| New | +$1.98M |
|
1531
Federal Realty Investment Trust
FRT
$8.77B
| $1.98M | ﹤0.01% |
14,328
-4,939
| -26% | -$681K |
|
1532
Heritage Commerce
HTBK
$624M
| $1.97M | ﹤0.01% |
162,482
-37,807
| -19% | -$457K |
|
1533
Albany International
AIN
$1.71B
| $1.96M | ﹤0.01% |
27,433
-3,763
| -12% | -$269K |
|
1534
Seres Therapeutics
MCRB
$139M
| $1.96M | ﹤0.01% |
14,265
-1,132
| -7% | -$156K |
|
1535
Ardelyx
ARDX
$1.59B
| $1.95M | ﹤0.01% |
697,513
+184,536
| +36% | +$517K |
|
|
OPB
1536
DELISTED
Opus Bank Common Stock
OPB
| $1.93M | ﹤0.01% |
97,609
+7,932
| +9% | +$157K |
|
1537
United Airlines
UAL
$34.5B
| $1.92M | ﹤0.01% |
24,046
+4,046
| +20% | +$323K |
|
1538
Evolution Petroleum
EPM
$179M
| $1.92M | ﹤0.01% |
283,922
+190,204
| +203% | +$1.28M |
|
1539
Enpro
NPO
$4.64B
| $1.92M | ﹤0.01% |
29,713
+3,957
| +15% | +$255K |
|
1540
Regional Management Corp
RM
$418M
| $1.91M | ﹤0.01% |
78,317
-1,766
| -2% | -$43.1K |
|
1541
Badger Meter
BMI
$5.24B
| $1.91M | ﹤0.01% |
34,326
+10,127
| +42% | +$563K |
|
1542
HealthEquity
HQY
$7.97B
| $1.91M | ﹤0.01% |
+25,799
| New | +$1.91M |
|
1543
Old Republic International
ORI
$10B
| $1.91M | ﹤0.01% |
91,187
-82,561
| -48% | -$1.73M |
|
1544
TherapeuticsMD
TXMD
$12.8M
| $1.9M | ﹤0.01% |
+7,806
| New | +$1.9M |
|
1545
Expro
XPRO
$1.43B
| $1.9M | ﹤0.01% |
50,898
-43,063
| -46% | -$1.6M |
|
1546
Macerich
MAC
$4.58B
| $1.89M | ﹤0.01% |
43,701
-121,719
| -74% | -$5.28M |
|
1547
Commercial Vehicle Group
CVGI
$72.9M
| $1.88M | ﹤0.01% |
245,357
+29,210
| +14% | +$224K |
|
1548
AerCap
AER
$21.8B
| $1.88M | ﹤0.01% |
40,411
-49,191
| -55% | -$2.29M |
|
|
PLYA
1549
DELISTED
Playa Hotels & Resorts
PLYA
| $1.87M | ﹤0.01% |
245,580
+7,528
| +3% | +$57.4K |
|
1550
Forward Air
FWRD
$904M
| $1.87M | ﹤0.01% |
28,851
+18,371
| +175% | +$1.19M |
|